Literature DB >> 16879901

Heterogeneity of influenza case definitions and implications for interpreting and comparing study results.

Kristin L Nichol1.   

Abstract

There is substantial heterogeneity with regard to influenza case definitions used in the medical literature. These different case definitions can vary substantially with regard to their sensitivity, specificity and positive and negative predictive values for confirmed influenza. Because of this heterogeneity, it is important that the appropriate case definitions be used to answer the specific questions of the study, with more specific definitions likely being used to answer questions of vaccine efficacy and more sensitive definitions being used to assess overall disease burden. When interpreting the results of studies and comparing results across studies it is essential that the issue of heterogeneity of case definitions be addressed, and that absolute risk reduction be used as the main outcome measure of interest rather than just the relative risk reduction.

Mesh:

Substances:

Year:  2006        PMID: 16879901     DOI: 10.1016/j.vaccine.2006.05.064

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  22 in total

1.  Design and initiation of a study to assess the direct and indirect effects of influenza vaccine given to children in rural India.

Authors:  Wayne Sullender; Karen Fowler; Anand Krishnan; Vivek Gupta; Lawrence H Moulton; Kathryn Lafond; Marc-Alain Widdowson; Renu B Lal; Shobha Broor
Journal:  Vaccine       Date:  2012-06-16       Impact factor: 3.641

2.  Influenza vaccination: policy versus evidence: no gap between policy and evidence.

Authors:  David S Fedson; Kristin L Nichol
Journal:  BMJ       Date:  2006-11-11

3.  Technical guidelines for the application of seasonal influenza vaccine in China (2014-2015).

Authors:  Luzhao Feng; Peng Yang; Tao Zhang; Juan Yang; Chuanxi Fu; Ying Qin; Yi Zhang; Chunna Ma; Zhaoqiu Liu; Quanyi Wang; Genming Zhao; Hongjie Yu
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

4.  The effect of sex on responses to influenza vaccines.

Authors:  Lucy Denly
Journal:  Hum Vaccin Immunother       Date:  2020-11-12       Impact factor: 3.452

5.  Trends in racial/ethnic disparities in influenza vaccination coverage among adults during the 2007-08 through 2011-12 seasons.

Authors:  Peng-Jun Lu; Alissa O'Halloran; Leah Bryan; Erin D Kennedy; Helen Ding; Samuel B Graitcer; Tammy A Santibanez; Ankita Meghani; James A Singleton
Journal:  Am J Infect Control       Date:  2014-05-03       Impact factor: 2.918

6.  Performance of case definitions used for influenza surveillance among hospitalized patients in a rural area of India.

Authors:  Siddhivinayak Hirve; Mandeep Chadha; Pallavi Lele; Kathryn E Lafond; Avinash Deoshatwar; Somnath Sambhudas; Sanjay Juvekar; Anthony Mounts; Fatimah Dawood; Renu Lal; Akhilesh Mishra
Journal:  Bull World Health Organ       Date:  2012-10-10       Impact factor: 9.408

7.  Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasons.

Authors:  Lisa A Jackson; Manjusha J Gaglani; Harry L Keyserling; John Balser; Nancy Bouveret; Louis Fries; John J Treanor
Journal:  BMC Infect Dis       Date:  2010-03-17       Impact factor: 3.090

8.  A placebo-controlled trial of Korean red ginseng extract for preventing influenza-like illness in healthy adults.

Authors:  Ki-Chan Ha; Min-Gul Kim; Mi-Ra Oh; Eun-Kyung Choi; Hyang-Im Back; Sun-Young Kim; Eun-Ok Park; Dae-Young Kwon; Hye-Jeong Yang; Min-Jeong Kim; Hee-Joo Kang; Ju-Hyung Lee; Kyung-Min Choi; Soo-Wan Chae; Chang-Seop Lee
Journal:  BMC Complement Altern Med       Date:  2012-02-08       Impact factor: 3.659

9.  A cell culture-derived influenza vaccine provides consistent protection against infection and reduces the duration and severity of disease in infected individuals.

Authors:  Hartmut J Ehrlich; Julia Singer; Gregory Berezuk; Sandor Fritsch; Gerald Aichinger; Mary Kate Hart; Wael El-Amin; Daniel Portsmouth; Otfried Kistner; P Noel Barrett
Journal:  Clin Infect Dis       Date:  2012-01-19       Impact factor: 9.079

10.  Challenge of conducting a placebo-controlled randomized efficacy study for influenza vaccine in a season with low attack rate and a mismatched vaccine B strain: a concrete example.

Authors:  Jirí Beran; Veronika Wertzova; Karel Honegr; Eva Kaliskova; Martina Havlickova; Jirí Havlik; Helena Jirincova; Pascale Van Belle; Varsha Jain; Bruce Innis; Jeanne-Marie Devaster
Journal:  BMC Infect Dis       Date:  2009-01-17       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.